Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-038977

COO and Secretary sold 10,000 shares at an average $64.55 ($645,500)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schuth Alexander O. COO and Secretary 2021-06-04 Sale −5,660 $64.35 $364,198 505,922 I: show line 1 in the form
Schuth Alexander O. COO and Secretary 2021-06-04 Sale −4,340 $64.82 $281,301 501,582 I: show line 2 in the form
Open-market sales · 10,000 sh · avg $64.55 · $645,500
Loading xslF345X03/doc4.xml…